Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan

Wenyu Ye1 Lilly Suzhou Pharmaceutical Co, Shanghai, People’s Republic of ChinaCorrespondence[email protected]

Haya Ascher-Svanum2 Eli Lilly and Company, Indianapolis, IN, USA

Yuka Tanji3 Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe

Jennifer A Flynn3 Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe

Michihiro Takahashi3 Lilly Research Laboratories Japan, Eli Lilly Japan KK, Kobe;4 Terauchi-Takahashi Psychiatric Clinic, Ashiya, Japan

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (6)

Masaomi Iyo, Hisashi Akiyoshi, Daisuke Sekine, Yoshiyuki Shibasaki & Noriyuki Mamiya. (2023) An exploratory database study of factors influencing the continuation of brexpiprazole treatment (prescription) in patients with schizophrenia using information from psychiatric electronic medical records processed with natural language processing. Schizophrenia Research 255, pages 122-131.
Crossref

Jun Ishigooka, Kazuyuki Nakagome, Tetsuro Ohmori, Nakao Iwata, Ken Inada, Jun‐ichi Iga, Taro Kishi, Kiyoshi Fujita, Yuka Kikuchi, Toshiaki Shichijo, Hideaki Tabuse, Shotatsu Koretsune, Hiroshi Terada, Haruko Terada, Toshifumi Kishimoto, Yuichiro Tsutsumi, Yoshiki Kanda, Kazutaka Ohi & Kanji Sekiyama. (2021) Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second‐generation antipsychotics: 52‐week evaluation of JUMPs , a randomized, open‐label study . Psychiatry and Clinical Neurosciences 76:1, pages 22-31.
Crossref

Jurjen J Luykx & Jari Tiihonen. (2021) Antipsychotic discontinuation: mind the patient and the real-world evidence. The Lancet Psychiatry 8:7, pages 555-557.
Crossref

Peter Joseph Jongen, Wim A. Lemmens, Erwin L. Hoogervorst & Rogier Donders. (2017) Glatiramer acetate treatment persistence - but not adherence - in multiple sclerosis patients is predicted by health-related quality of life and self-efficacy: a prospective web-based patient-centred study (CAIR study). Health and Quality of Life Outcomes 15:1.
Crossref

Steffen Moritz, Alexandra Hünsche & Tania M. Lincoln. (2014) Nonadherence to antipsychotics: The role of positive attitudes towards positive symptoms. European Neuropsychopharmacology 24:11, pages 1745-1752.
Crossref

Michihiro Takahashi, Shinji Fujikoshi, Jumpei Funai, Levent Alev & Masaomi Iyo. (2014) Predictors of Discontinuation of Antipsychotic Therapy in Patients with Acute Schizophrenia: A 1-Year Observational Study with More Than 1000 Patients. Open Journal of Psychiatry 04:04, pages 364-371.
Crossref

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan

Articles from other publishers (6)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan

Citations (6)

Articles from other publishers (6)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date